CO-PROMOTION AGREEMENTCo-Promotion Agreement • February 29th, 2016 • Eagle Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 29th, 2016 Company Industry JurisdictionThis Co-Promotion Agreement (this “Agreement”) is entered into as of November 4, 2015 (the “Effective Date”), by and between Eagle Pharmaceuticals, Inc., a corporation organized under the laws of Delaware with offices at 50 Tice Blvd., Suite 315, Woodcliff Lake, NJ 07677 (“Eagle”) and Spectrum Pharmaceuticals, Inc., a corporation organized under the laws of Delaware with offices at 11500 South Eastern Avenue, Suite 240, Henderson, Nevada 89052 (“Spectrum”). Each of Eagle and Spectrum is sometimes referred to individually herein as a “Party” and collectively as the “Parties.”
LICENSE AGREEMENTLicense Agreement • February 29th, 2016 • Eagle Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 29th, 2016 Company Industry JurisdictionThis LICENSE AGREEMENT (this “Agreement”), dated as of October 13, 2015 (the “Effective Date”), is made by and between Eagle Pharmaceuticals, Inc., a Delaware corporation having its principal office at 50 Tice Boulevard, Suite 315, Woodcliff Lake, NJ 07677 (“Licensee”), and Teikoku Pharma USA, Inc., a California corporation having its principal office at 1718 Ringwood Avenue, San Jose, CA 95131 (“Teikoku”). Licensee and Teikoku are each sometimes referred to individually as a “Party” and together as the “Parties.”